Bird & Bird advised Patria on its acquisition of Nordic Drones

International law firm Bird & Bird acted as legal advisor to Patria Oyj, on its acquisition of 100 % of the shares in Nordic Drones Oy.

Patria is an international provider of defence, security and aviation life cycle support services, technology solutions and pilot training. Nordic Drones is a Finnish company located in Muurame, manufacturing drones designed for professional use. The completion of the transaction is subject to customary closing conditions. 

The Bird & Bird team was led by partner Mikko Ahonen, primarily assisted by associate Marla Melin. Other team members included Counsel Riikka Aarikka and associate Maria Karpathakis (EU & Competition), Counsel Juuso Pyy, and associates Teemu Lahdelma, and Niilo-Pekka Salminen (Tech & Comms), partner Henri Kaikkonen and associate Sofia Paksuniemi (IP), partner Teea Kemppinen and associate Johanna Salonen (Employment), associate Anna-Kaisa Mäenpää (Finance & Financial Regulation), as well as partner Ville Alahuhta and associate Matias Vikström (Tax).

With our expertise in the technology and defence sectors, we were able to provide the client with valuable guidance, navigating complex regulatory requirements and providing advice on industry-specific issues.

 

News & Deals

More News & Deals

News

Bird & Bird strengthens Finance Services Sector Group in France with new partner

Feb 10 2025

Read More

Deal

Bird & Bird advises Gamma on the agreement to acquire STARFACE from Maxburg

Feb 07 2025

Read More

Deal

Bird & Bird advised the African Development Bank on $100 million financing of Sucden

Feb 04 2025

Read More

News

Bird & Bird hires Susan Battye to lead the employment practice in Ireland

Jan 28 2025

Read More

Deal

Bird & Bird and Sheppard Mullin Represent Buyers in the Majority Sale of Championship Football Club, Swansea City AFC

Jan 27 2025

Read More

Deal

Bird & Bird advised Bpifrance’s Large Venture on Series A financing round of Bioptimus, a specialist in AI applied to innovation in biomedicine

Jan 22 2025

Read More